APA (7th ed.) Citation

Mohr, P., & Enk, A. (2015). Intermittent high-dose intravenous interferon Alfa-2b for adjuvant treatment of stage III melanoma: Final analysis of a randomized phase III dermatologic cooperative oncology group trial. Journal of clinical oncology, 33(34), . https://doi.org/10.1200/JCO.2014.59.6932

Chicago Style (17th ed.) Citation

Mohr, Peter, and Alexander Enk. "Intermittent High-dose Intravenous Interferon Alfa-2b for Adjuvant Treatment of Stage III Melanoma: Final Analysis of a Randomized Phase III Dermatologic Cooperative Oncology Group Trial." Journal of Clinical Oncology 33, no. 34 (2015). https://doi.org/10.1200/JCO.2014.59.6932.

MLA (9th ed.) Citation

Mohr, Peter, and Alexander Enk. "Intermittent High-dose Intravenous Interferon Alfa-2b for Adjuvant Treatment of Stage III Melanoma: Final Analysis of a Randomized Phase III Dermatologic Cooperative Oncology Group Trial." Journal of Clinical Oncology, vol. 33, no. 34, 2015, https://doi.org/10.1200/JCO.2014.59.6932.